Atara Biotherapeutics(ATRA)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ATRA Atara Biotherapeutics

盘前交易 05-17 09:25:01 EDT

0.6036

-0.0364

-5.69%

盘前0.6245

+0.0209+3.46%

08:54 EDT

最高0.6599	最低0.5963	成交量112.62万
今开0.6327	昨收0.6400	日振幅9.94%
总市值7,268万	流通市值5,531万	总股本1.20亿
成交额69.69万	换手率1.23%	流通股本9,163万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ATRA","market":"US","secType":"STK","nameCN":"Atara Biotherapeutics","latestPrice":0.6036,"timestamp":1715889600000,"preClose":0.64,"halted":0,"volume":1126184,"hourTrading":{"tag":"盘前","latestPrice":0.6245,"preClose":0.6036,"latestTime":"08:54 EDT","volume":4268,"amount":2681.7687776,"timestamp":1715950496997},"delay":0,"floatShares":91625855,"shares":120416138,"eps":-2.030159,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.0364,"latestTime":"05-17 09:25:01 EDT","open":0.6327,"high":0.6599,"low":0.5963,"amount":696914.9806808,"amplitude":0.099375,"askPrice":0.6833,"askSize":3200,"bidPrice":0.574,"bidSize":3200,"shortable":3,"etf":0,"ttmEps":-2.030159,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715952600000},"adr":0,"listingDate":1413432000000,"adjPreClose":0.6036,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":0.6245,"preClose":0.6036,"latestTime":"08:54 EDT","volume":4268,"amount":2681.7687776,"timestamp":1715950496997},"postHourTrading":{"tag":"盘后","latestPrice":0.6164,"preClose":0.6036,"latestTime":"19:54 EDT","volume":15809,"amount":9565.3069,"timestamp":1715903673147},"volumeRatio":0.6423563583293691},"requestUrl":"/m/hq/s/ATRA","defaultTab":"news","newsList":[{"id":"2435551023","title":"Atara Biotherapeutics, Inc.盘中异动 早盘大幅拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435551023","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435551023?lang=zh_cn&edition=full","pubTime":"2024-05-14 23:22","pubTimestamp":1715700178,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日23时22分，Atara Biotherapeutics, Inc.股票出现异动，股价急速上涨5.14%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Tc Biopharm  Plc C/Wts 10/02/2028 、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.、诺瓦瓦克斯医药较为活跃，换手率分别为108.02%、48.93%、22.20%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Alzamend Neuro, Inc.，振幅分别为69.43%、65.80%、41.58%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240514232259861ed21c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240514232259861ed21c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435985379","title":"Atara Biotherapeutics, Inc.盘中异动 早盘急速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435985379","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435985379?lang=zh_cn&edition=full","pubTime":"2024-05-13 22:32","pubTimestamp":1715610756,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日22时32分，Atara Biotherapeutics, Inc.股票出现波动，股价快速下挫5.00%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.10%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Jasper Therapeutics Inc C/Wts 24/09/2026 、诺瓦瓦克斯医药涨幅较大，Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.、诺瓦瓦克斯医药较为活跃，换手率分别为62.66%、37.16%、22.34%，振幅较大的相关个股有Tevogen Bio Holdings Inc.、Dbv Technologies、Portage Biotech Inc.，振幅分别为43.68%、36.84%、34.80%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513223237861ecd71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513223237861ecd71&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434485497","title":"Atara Biotherapeutics, Inc.盘中异动 早盘大幅拉升5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434485497","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434485497?lang=zh_cn&edition=full","pubTime":"2024-05-10 21:32","pubTimestamp":1715347952,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日21时32分，Atara Biotherapeutics, Inc.股票出现异动，股价快速拉升5.59%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，诺瓦瓦克斯医药、Clene Inc C/Wts 30/12/2025 、Artelo Biosciences Inc C/Wts 20/06/2024 涨幅较大，诺瓦瓦克斯医药、Allarity Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为32.69%、17.59%、6.65%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、诺瓦瓦克斯医药、内克塔治疗，振幅分别为31.88%、20.58%、12.50%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102132328af137de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102132328af137de&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434028236","title":"Atara Biotherapeutics Inc 报告截至三月份的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2434028236","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2434028236?lang=zh_cn&edition=full","pubTime":"2024-05-10 04:48","pubTimestamp":1715287703,"startTime":"0","endTime":"0","summary":"   * Atara Biotherapeutics Inc   报告，截至3月底的季度调整后每股亏损23美分，高于去年同期的每股-72美分。四位分析师对该季度的平均预期是每股亏损 26 美分。华尔街预期为每股-33美分至-17美分。* Atara Biotherapeutics Inc的股价本季度下跌了18.5%，今年迄今为止上涨了10.3%。5月9日 - 预测变化   * 在过去三个月里，分析师的平均盈利预期上升了约 45.5%。华尔街对 Atara Biotherapeutics Inc 的 12 个月目标价中位数为 1.65 美元。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433789052","title":"Atara Biotherapeutics, Inc.盘中异动 早盘股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433789052","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433789052?lang=zh_cn&edition=full","pubTime":"2024-05-07 22:54","pubTimestamp":1715093663,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日22时54分，Atara Biotherapeutics, Inc.股票出现异动，股价急速跳水5.21%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Geovax Labs Inc C/Wts 29/09/2025、珐博进涨幅较大，Clearmind Medicine Inc.、Allarity Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为1395.34%、179.67%、170.06%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、珐博进、Sab Biotherapeutics Inc C/Wts 22/10/2026 ，振幅分别为41.69%、41.38%、38.52%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240507225423861eb7eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240507225423861eb7eb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432975980","title":"Atara Biotherapeutics Inc   预计每股亏损26美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432975980","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432975980?lang=zh_cn&edition=full","pubTime":"2024-05-03 19:54","pubTimestamp":1714737279,"startTime":"0","endTime":"0","summary":"   * Atara Biotherapeutics Inc    将于5月6日公布截至2024年3月31日的季度业绩(估计)，预计该公司的季度收入将出现增长。* LSEG 分析师对 Atara Biotherapeutics Inc 的平均预期是每股亏损 26 美分。* 华尔街对 Atara Biotherapeutics Inc 的 12 个月目标价中位数为 1.65 美元，高于上一次 0.65 美元的收盘价。5月3日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432044396","title":"Atara Biotherapeutics, Inc.盘中异动 早盘股价大跌5.04%报0.650美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432044396","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432044396?lang=zh_cn&edition=full","pubTime":"2024-05-02 21:48","pubTimestamp":1714657701,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日21时48分，Atara Biotherapeutics, Inc.股票出现异动，股价大幅跳水5.04%。截至发稿，该股报0.650美元/股，成交量34.4914万股，换手率0.29%，振幅6.75%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.、Context Therapeutics Inc.涨幅较大，Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.、Context Therapeutics Inc.较为活跃，换手率分别为2407.15%、385.16%、102.01%，振幅较大的相关个股有Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.、Fresh2 Group Limited，振幅分别为73.72%、28.13%、24.08%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502214821861eab10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502214821861eab10&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432570870","title":"Atara Biotherapeutics, Inc.盘中异动 早盘快速上涨6.57%报0.735美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432570870","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432570870?lang=zh_cn&edition=full","pubTime":"2024-05-01 21:36","pubTimestamp":1714570607,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日21时36分，Atara Biotherapeutics, Inc.股票出现异动，股价快速拉升6.57%。截至发稿，该股报0.735美元/股，成交量1.6796万股，换手率0.01%，振幅1.93%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Cytomx Therapeutics, Inc.、Tg Therapeutics, Inc.、Palisade Bio, Inc.涨幅较大，Palisade Bio, Inc.、Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为437.18%、37.65%、14.97%，振幅较大的相关个股有Carmell Corporation、Cytomx Therapeutics, Inc.、Palisade Bio, Inc.，振幅分别为21.50%、19.63%、14.93%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012136477925a0a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012136477925a0a7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431784182","title":"Atara Biotherapeutics, Inc.盘中异动 大幅拉升5.01%报0.725美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431784182","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431784182?lang=zh_cn&edition=full","pubTime":"2024-04-30 03:22","pubTimestamp":1714418577,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日03时22分，Atara Biotherapeutics, Inc.股票出现波动，股价急速拉升5.01%。截至发稿，该股报0.725美元/股，成交量75.0752万股，换手率0.63%，振幅8.97%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Zura Bio Limited C/Wts 、Celularity Inc C/Wts 16/07/2026 涨幅较大，Zyversa Therapeutics, Inc.、Annovis Bio, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为1033.77%、82.11%、64.93%，振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Annovis Bio, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为98.32%、79.12%、75.06%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043003225779251d3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043003225779251d3a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430751286","title":"Atara Biotherapeutics, Inc.盘中异动 股价大跌5.93%报0.672美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430751286","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430751286?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:48","pubTimestamp":1714052924,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时48分，Atara Biotherapeutics, Inc.股票出现异动，股价快速下挫5.93%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.37%。其相关个股中，Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Zura Bio Limited C/Wts 、Processa Pharmaceuticals, Inc.涨幅较大，Processa Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.、Cidara Therapeutics, Inc.较为活跃，换手率分别为1180.71%、197.05%、8.11%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Processa Pharmaceuticals, Inc.、Artelo Biosciences Inc C/Wts 20/06/2024 ，振幅分别为40.85%、30.86%、19.29%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042521484487e83b6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042521484487e83b6e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428675664","title":"Atara Biotherapeutics, Inc.盘中异动 快速下挫5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428675664","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428675664?lang=zh_cn&edition=full","pubTime":"2024-04-20 00:58","pubTimestamp":1713545918,"startTime":"0","endTime":"0","summary":"北京时间2024年04月20日00时58分，Atara Biotherapeutics, Inc.股票出现异动，股价急速下跌5.44%。截至发稿，该股报0.654美元/股，成交量67.0629万股，换手率0.56%，振幅6.98%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Nkgen Biotech, Inc.、Chromocell Therapeutics Corporation涨幅较大，Bio-Path Holdings, Inc.、Kintara Therapeutics, Inc.、Palisade Bio, Inc.较为活跃，换手率分别为229.37%、14.87%、11.33%，振幅较大的相关个股有Nkgen Biotech, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Humacyte Inc C/Wts 27/08/2026 ，振幅分别为62.28%、46.41%、38.01%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240420005838861e77fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240420005838861e77fe&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428349906","title":"Atara Biotherapeutics, Inc.盘中异动 早盘快速上涨5.34%报0.718美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428349906","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428349906?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:44","pubTimestamp":1713361443,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时44分，Atara Biotherapeutics, Inc.股票出现异动，股价大幅上涨5.34%。截至发稿，该股报0.718美元/股，成交量2.7933万股，换手率0.02%，振幅6.26%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Vanda Pharmaceuticals Inc.、Igc Pharma, Inc.涨幅较大，Clearmind Medicine Inc.、Longeveron Inc.、Novabay Pharmaceuticals, Inc.较为活跃，换手率分别为25.91%、24.40%、24.26%，振幅较大的相关个股有Ocean Biomedical Inc C/Wts 14/02/2028 、Cassava Sciences Inc C/Wts 15/11/2024、Igc Pharma, Inc.，振幅分别为27.34%、26.44%、25.51%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417214403792141aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417214403792141aa&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426973034","title":"Atara Biotherapeutics, Inc.盘中异动 早盘股价大跌7.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426973034","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426973034?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:37","pubTimestamp":1712756273,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时37分，Atara Biotherapeutics, Inc.股票出现异动，股价快速跳水7.09%。截至发稿，该股报0.696美元/股，成交量5.4994万股，换手率0.05%，振幅5.22%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.27%。其相关个股中，Adial Pharmaceuticals, Inc、Tc Biopharm  Plc C/Wts 10/02/2028 、Jaguar Health, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Abvc Biopharma, Inc.较为活跃，换手率分别为1129.27%、69.26%、25.38%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Calidi Biotherapeutics, Inc.，振幅分别为47.79%、24.26%、23.22%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213753861e4a66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213753861e4a66&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424418315","title":"Atara Biotherapeutics, Inc.盘中异动 早盘股价大涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424418315","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424418315?lang=zh_cn&edition=full","pubTime":"2024-04-04 22:48","pubTimestamp":1712242128,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日22时48分，Atara Biotherapeutics, Inc.股票出现异动，股价大幅拉升5.28%。Atara Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Tc Biopharm  Plc、Tc Biopharm  Plc C/Wts 10/02/2028 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Tc Biopharm  Plc、Effector Therapeutics, Inc.、Candel Therapeutics, Inc.较为活跃，换手率分别为3025.27%、134.54%、66.45%，振幅较大的相关个股有Tc Biopharm  Plc、Tc Biopharm  Plc C/Wts 10/02/2028 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为90.00%、70.00%、50.00%。Atara Biotherapeutics, Inc.公司简介：Atara Biotherapeutics Inc 在美国医疗保健行业开展业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404042248487a51076e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404042248487a51076e&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.atarabio.com","stockEarnings":[{"period":"1week","weight":0.1059},{"period":"1month","weight":-0.1144},{"period":"3month","weight":-0.2167},{"period":"6month","weight":0.1835},{"period":"1year","weight":-0.707},{"period":"ytd","weight":0.1771}],"compareEarnings":[{"period":"1week","weight":0.0164},{"period":"1month","weight":0.05},{"period":"3month","weight":0.0584},{"period":"6month","weight":0.1728},{"period":"1year","weight":0.2732},{"period":"ytd","weight":0.1123}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Atara Biotherapeutics, Inc.于2012年8月22日在特拉华州成立。公司是一个临床阶段的生物制药公司，致力于开发对肌肉萎缩情况和肿瘤学严重的未满足的医疗需求的新疗法。公司的候选产品是针对肌肉生长抑制素和激活素生物制剂，是TGF-β蛋白超家族的成员，它在肌肉和其他许多身体组织的生长和维持中发挥作用。公司的主导候选产品，PINTA745，是在终末期肾病患者的第2阶段临床试验PEW。该公司第二候选产品为STM434，以及该公司预计将在2014年下半年进入STM434的第1阶段临床研究卵巢癌等实体瘤。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.120552},{"month":2,"riseRate":0.3,"avgChangeRate":-0.046815},{"month":3,"riseRate":0.5,"avgChangeRate":0.062248},{"month":4,"riseRate":0.1,"avgChangeRate":-0.077789},{"month":5,"riseRate":0.4,"avgChangeRate":-0.069381},{"month":6,"riseRate":0.777778,"avgChangeRate":0.128062},{"month":7,"riseRate":0.555556,"avgChangeRate":-0.068572},{"month":8,"riseRate":0.555556,"avgChangeRate":-0.016397},{"month":9,"riseRate":0.666667,"avgChangeRate":0.009953},{"month":10,"riseRate":0.111111,"avgChangeRate":-0.128758},{"month":11,"riseRate":0.8,"avgChangeRate":0.240727},{"month":12,"riseRate":0.2,"avgChangeRate":-0.11122}],"exchange":"NASDAQ","name":"Atara Biotherapeutics","nameEN":"Atara Biotherapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Atara Biotherapeutics(ATRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Atara Biotherapeutics(ATRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Atara Biotherapeutics,ATRA,Atara Biotherapeutics股票,Atara Biotherapeutics股票老虎,Atara Biotherapeutics股票老虎国际,Atara Biotherapeutics行情,Atara Biotherapeutics股票行情,Atara Biotherapeutics股价,Atara Biotherapeutics股市,Atara Biotherapeutics股票价格,Atara Biotherapeutics股票交易,Atara Biotherapeutics股票购买,Atara Biotherapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Atara Biotherapeutics(ATRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Atara Biotherapeutics(ATRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况